| Literature DB >> 33199326 |
Sophie Kelly1, Laura Waters2, Muge Cevik3, Simon Collins4, Joe Lewis1, Meng-San Wu5, Tom J Blanchard1, Anna M Geretti6.
Abstract
While clinical environments are highly focused on COVID-19, reports of missed or delayed treatment for conditions that imitate COVID-19, such as pneumonia caused by the fungus Pneumocystis jirovecii, are emerging. Given the uncertain spectrum of COVID-19 presentations and variable sensitivity of laboratory tests for SARS-CoV-2, there is a risk that, without a high index of suspicion, alternative aetiologies may be overlooked while pursuing a diagnosis of COVID-19. The British HIV Association has been calling for the inclusion of HIV testing in all patients admitted to hospital with suspected COVID-19. In this article we reflect on the importance of including HIV testing to prevent avoidable morbidity and mortality in our patients. © Royal College of Physicians 2020. All rights reserved.Entities:
Keywords: COVID-19; HIV; PCP; Pneumocystis jirovecii; SARS-CoV-2
Mesh:
Year: 2020 PMID: 33199326 PMCID: PMC7687333 DOI: 10.7861/clinmed.2020-0565
Source DB: PubMed Journal: Clin Med (Lond) ISSN: 1470-2118 Impact factor: 2.659